Moreover, plasma levels of soluble CD40L have been proposed as a biomarker for cardiovascular risk; in particular, several studies have established a positive correlation of sCD40L with cardio-metabolic risk factors, such as dyslipidemia, diabetes, and obesity (112–114). The gene discussed is CD40LG; the disease is diabetes mellitus.